Researchers from the Swiss National Science Foundation (SNSF) have developed a technique to identify which Ewing’s sarcoma cancer cells are most likely to trigger metastases and spread cancer within the body, the SNSF said in a statement on Wednesday.
Ewing’s sarcoma is a rare but very aggressive form of bone cancer that particularly affects children and young adults.
The scientists began by isolating the most dangerous cancer cells and growing them in a laboratory. They then genetically modified the tumour cells, introducing a gene that causes the dangerous cells to glow green if the cell is of the metastasising variety. The work has been published in the journal Science Advances.
More
More
Swiss-led research team uncovers key to treatment-resistant prostate cancer
This content was published on
A team led by the University of Bern has identified a key factor that causes some advanced prostate cancer to become resistant to hormonal therapy.
“Identifying the gene associated with the risk of metastases opens new avenues for research”, said Ivan Stamenkovic, co-author of the paper and professor of experimental pathology at the University Hospital Lausanne (CHUV).
It is hoped that identifying the most dangerous cancer cells will open the door for treatments that target specific cells, Stamenkovic said.
Popular Stories
More
Swiss Abroad
The Swiss Alps, a new Eldorado for real estate developers
Should Switzerland take measures to support its struggling industries?
Industrial policies are back in fashion, not only in the United States but also in the EU. Should Switzerland, where various industries are struggling, draw inspiration from such policies?
As a Swiss Abroad, how do you feel about the emergence of more conservative family policies in some US states?
In recent years several US states have adopted more conservative policies on family issues, abortion and education. As a Swiss citizen living there, how do you view this development?
Swiss authorities file criminal complaint for false signatures
This content was published on
The case of allegedly forged signatures for popular initiatives in Switzerland continues: the Federal Chancellery has filed a criminal complaint for the third time.
Swiss government must prioritise transport projects
This content was published on
Following the no to motorway expansions and additional costs for future rail infrastructure, the Swiss government must set priorities for road and rail expansion.
SMI back above 12,500 points for first time since beginning of 2022
This content was published on
The leading SMI index rose by almost 1% at times in the morning and traded above 12,500 points for the first time since the beginning of 2022.
Markus Ritter enters race for seat in Swiss government
This content was published on
Markus Ritter from the Centre Party has thrown his hat into the ring to succeed Defence Minister Viola Amherd on the seven-seat Swiss government.
Lausanne hospital produces drug from faecal bacteria
This content was published on
The University Hospital of canton Vaud (Chuv) is the first Swiss hospital to receive approval for the production of such drugs from donor stool.
Increase in heat deaths set to outweigh decrease in cold deaths
This content was published on
The growing number of heat-related deaths due to climate change will significantly exceed the decline in the number of cold-related deaths in Europe, according to a study.
Every second Swiss buys from Chinese online retailers
This content was published on
Chinese online retailers are becoming increasingly popular in Switzerland. Every other person has already made such a purchase in the past year.
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.
Read more
More
Swiss-led research team uncovers key to treatment-resistant prostate cancer
This content was published on
A team led by the University of Bern has identified a key factor that causes some advanced prostate cancer to become resistant to hormonal therapy.
This content was published on
Ahead of National Skin Cancer Day on Monday, the professor explains why the Swiss are so at risk and what the warning signs are for the illness. Panizzon, who is chairman of the dermatology department at Lausanne University Hospital, is one of 150 doctors around the country who will be conducting free consultations on National…
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.